Clinical and economic impact of contaminated blood cultures within the hospital setting

Journal of Hospital Infection

Volumn 77, Issue 3, 2011, Pages 233-236

  Alahmadi, Y M ^a   Aldeyab, M A ^a   McElnay, J C ^a   Scott, M G ^b   Darwish Elhajji, F W ^a   Magee, F A ^b   Dowds, M ^b   Edwards, C ^b   Fullerton, L ^c   Tate, A ^c   Kearney, M P ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b NORTHERN HEALTH AND SOCIAL CARE TRUST   (United Kingdom)

^c Iskus Health Ltd   (Ireland)

Author keywords

Blood cultures; Cost effectiveness; False positives

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD CULTURE; COMORBIDITY; CONTROLLED STUDY; DRUG COST; FALSE POSITIVE RESULT; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HOSPITAL ADMISSION; HOSPITAL BASED CASE CONTROL STUDY; HOSPITALIZATION COST; HUMAN; LABORATORY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MICROBIAL CONTAMINATION; MICROBIOLOGICAL EXAMINATION; RADIOGRAPHY; RETROSPECTIVE STUDY; SCORING SYSTEM;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; BLOOD; BLOOD SPECIMEN COLLECTION; CASE-CONTROL STUDIES; COST-BENEFIT ANALYSIS; CROSS INFECTION; CULTURE MEDIA; EQUIPMENT CONTAMINATION; FALSE POSITIVE REACTIONS; FEMALE; HOSPITAL COSTS; HOSPITALS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 79951855666     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2010.09.033     Document Type: Article

References (19)

1. Rello J. Impact of nosocomial infections on outcome: myths and evidence. Infect Control Hosp Epidemiol 1999, 20:392-394.
2. Orsi G.B., Di Stefano L., Noah N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol 2002, 23:190-197.
3. Peters R.P., van Agtmael M.A., Danner S.A., Savelkoul P.H., Vandenbroucke-Grauls C.M. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 2004, 4:751-760.
4. Bates D.W., Goldman L., Lee T.H. Contaminant blood cultures and resource utilization. The true consequences of false-positive results. JAMA 1991, 265:365-369.
5. Weinbaum F.I., Lavie S., Danek M., Sixsmith D., Heinrich G.F., Mills S.S. Doing it right the first time: quality improvement and the contaminant blood culture. J Clin Microbiol 1997, 35:563-565.
6. Zwang O., Albert R.K. Analysis of strategies to improve cost effectiveness of blood cultures. J Hosp Med 2006, 1:272-276.
7. Weinstein M.P. Blood culture contamination: persisting problems and partial progress. J Clin Microbiol 2003, 41:2275-2278.
8. Souvenir D., Anderson D.E., Palpant S., et al. Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients. J Clin Microbiol 1998, 36:1923-1926.
9. Surdulescu S., Utamsingh D., Shekar R. Phlebotomy teams reduce blood-culture contamination rate and save money. Clin Perform Qual Health Care 1998, 6:60-62.
10. Widmer A.F. Sterilization of skin and catheters before drawing blood cultures. J Clin Microbiol 2003, 41:4910.
11. Pavlovsky M., Press J., Peled N., Yagupsky P. Blood culture contamination in pediatric patients: young children and young doctors. Pediatr Infect Dis J 2006, 25:611-614.
12. Gander R.M., Byrd L., DeCrescenzo M., Hirany S., Bowen M., Baughman J. Impact of blood cultures drawn by phlebotomy on contamination rates and health care costs in a hospital emergency department. J Clin Microbiol 2009, 47:1021-1024.
13. Schifman R.B., Strand C.L., Meier F.A., Howanitz P.J. Blood culture contamination: a College of American Pathologists Q-Probes study involving 640 institutions and 497134 specimens from adult patients. Arch Pathol Lab Med 1998, 122:216-221.
14. Tobacman J.K. Assessment of comorbidity: a review. Clin Perform Qual Health Care 1994, 2:23-32.
15. Modena S., Bearelly D., Swartz K., Friedenberg F.K. Clostridium difficile among hospitalized patients receiving antibiotics: a case-control study. Infect Control Hosp Epidemiol 2005, 26:685-690.
16. Hall K.K., Lyman J.A. Updated review of blood culture contamination. Clin Microbiol Rev 2006, 19:788-802.
17. Quan H., Sundararajan V., Halfon P., et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005, 43:1130-1139.
18. de Groot V., Beckerman H., Lankhorst G.J., Bouter L.M. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 2003, 56:221-229.
19. Gibb A.P., Hill B., Chorel B., Brant R. Reduction in blood culture contamination rate by feedback to phlebotomists. Arch Pathol Lab Med 1997, 121:503-507.